Home English Tumor vs. Germline Testing: What’s the Difference? Tumor vs. Germline Testing: What’s the Difference? Share on Facebook Share on LinkedIn Share on Twitter Copy this URL Share via Email In this informative webinar, Scott Weissman, MS, CGC, explains the difference between tumor testing and germline testing so you can better understand the tests you receive as a colorectal cancer patient and what they mean for you. There are a variety of tests that you may face during the process of your diagnosis which will likely affect your treatment decision making. Watch the Webinar View the Slides Dec. Webinar - Tumor vs. Germline Testing: What’s the Difference? from Fight Colorectal Cancer ABOUT THE PRESENTER - Scott M. Weissman, MS, CGC Scott M. Weissman is the founder of Chicago Genetic Consultants, LLC, a private genetic counseling practice.He received his Bachelor of Science degree in Biology from the University of Illinois at Urbana-Champaign in 1998.After graduation, he spent two years working in a clinical genetic testing laboratory at the University of Illinois at Chicago performing testing to monitor minimal residual disease in individuals affected by leukemia or lymphoma.In 2002, he graduated from Northwestern University in Chicago with his Masters of Science in Genetic Counseling. Scott practiced clinically at NorthShore University HealthSystem for 12 years and was the Program Manager at the Center for Medical Genetics.His primary focus was hereditary cancer syndromes (e.g., BRCA1/2, Lynch syndrome, hereditary diffuse gastric cancer) but also worked with individuals who had hereditary cardiac disease, neurologic conditions as well as a multitude of other adult onset genetic conditions and the burgeoning area of pharmacogenomics. He also has experience with new genetic testing technologies and Next Generation Sequencing from his time with GeneDx, a clinical genetic testing company.Scott is currently a Clinical Faculty member at the Northwestern University Graduate Program in Genetic Counseling. He has been an active member of the National Society of Genetic Counselors (NSGC) where he has worked on a variety of committees and held positions as the Co-Chair of the Familial Cancer Risk Special Interest Group and Liaison to both the Commission on Cancer and the National Accreditation Program of Breast Centers, two programs housed in the American College of Surgeons. Scott is well known among his peers for his extensive work in the field and has authored numerous scholarly articles that have appeared in several prestigious publications such as Genetics in Medicine, Cancer, The Journal of the American Medical Association, and Journal of Genetic Counseling, to name a few. SPONSORED BY: